Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2017

Mar 10, 2017

30681_dirs_2017-03-10_d1886fa8-ea41-4de8-b19d-77c90f9c4f3e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2017-03-08

Reporting Person: ENRIGHT PATRICK G (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-03-08 Common Stock S 735263 $9.75 Disposed 7554582 Indirect
2017-03-08 Common Stock S 14737 $9.75 Disposed 151420 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 204210 Direct

Footnotes

F1: Reflects shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Partners, L.P. ("LCA"). Mr. Enright is a managing member of Longitude Capital Partners, LLC, the sole general partner of LVP and LCA. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held of record by LVP and LCA, except to the extent of his pecuniary interest therein.